期刊文献+

HPLC法测定创新药Y101片剂中3个光学异构体的含量 被引量:2

HPLC determination of three optical isomers in Y101 tablets
原文传递
导出
摘要 目的:建立高效液相色谱法测定Y101片剂中3个光学异构体含量的方法。方法:采用DAICEL CHIRALPAK AD-H手性柱(250 mm×4.6 mm,5μm),流动相为正己烷-异丙醇-二乙胺(85∶15∶0.1),流速0.8 mL.min-1,柱温30℃,检测波长226 nm,进样量40μL。结果:Y101与3个光学异构体分离良好,Y101检测浓度的线性范围为0.1042~0.8336μg.mL-1(r=0.9999),检测限为2.9176 ng。结论:该方法操作简便,结果准确,可用于Y101片剂中3个光学异构体的含量测定并控制其异构体的限度。 Objective:To establish an HPLC method for the determination of three optical isomers in Y101 tablets. Method :The separation was performed on an DAICEL CHIRALPAK AD - H ehiral column (250 mm x 4. 6 mm, 5 txm). The mobile phase was n -hexane -/so -propylaleohol -diethylamine(85: 15: 0. 1 )at a flow rate of 0. 8 mL· min^-1. The column temperature was 30℃, and the detection wavelength was set at 226 nm. The injection volume was 40 μL. Results:Y101 and three optical isomers were well separated. The linear range of Y101 was 0. 1042 -0. 8336μg · mL^-1 (r =0. 9999) ,the detection limit was 2. 9176 ng. Conclusion:The method is proved to be simple and accu- rate ,which is suitable for the content determination and purity determination of three optical isomers in Y101 tablets.
出处 《药物分析杂志》 CAS CSCD 北大核心 2013年第2期189-192,共4页 Chinese Journal of Pharmaceutical Analysis
基金 国家973课题-基于释药动力学的非晶态给药体系的评价方法研究(2012CB724002) 国家生物医药国际创新园(天津)创新药物孵化基地建设(2010ZX09401)
关键词 高效液相色谱法 手性柱 N-[N-苯甲酰基-O-(2-二乙氨基乙基)-L-酪氨酰基]-L-苯丙氨醇 Y101 光学异构体含量测定 创新药质量控制 HPLC chiral column N - [ N - benzoyl - 0 - (2 - diethyllaminoethyl) - L - tyrosyl ] - phenylalaninealcohol Y101 optical isomer content determination original of new drug quality control
  • 相关文献

参考文献6

二级参考文献26

共引文献73

同被引文献7

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部